Associations of depression with c-reactive protein, IL-1, and IL-6: A meta-analysis

Psychosomatic Medicine

Volumn 71, Issue 2, 2009, Pages 171-186

  Howren, M Bryant ^a   Lamkin, Donald M ^a   Suls, Jerry ^a  

^a E11 SSH   (United States)

Author keywords

C reactive protein; Depression; Inflammation; Interleukin 1; Interleukin 6; Meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 6; NON PRESCRIPTION DRUG; IL6 PROTEIN, HUMAN;

ARTICLE; BODY MASS; CANCER RISK; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; HEART DISEASE; HUMAN; INFLAMMATION; INFORMATION RETRIEVAL; INTERVIEW; MEDLINE; NEOPLASM; ORAL CONTRACEPTION; PRIORITY JOURNAL; PSYCINFO; SYSTEMATIC REVIEW; ADULT; AGE; BLOOD; COMORBIDITY; EPIDEMIOLOGY; FEMALE; MALE; META ANALYSIS; REVIEW; SEX DIFFERENCE;

ADULT; AGE FACTORS; BODY MASS INDEX; C-REACTIVE PROTEIN; CAUSALITY; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HEART DISEASES; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; MALE; NEOPLASMS; SEX FACTORS;

EID: 65649152524     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181907c1b     Document Type: Article

References (172)

1. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry 2005;62: 1097-106.
2. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
3. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
4. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999;318:1460-7.
5. Carney RM, Rich MW, Freedland KE, Saini J, TeVelve A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
6. Barefoot J, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-80.
7. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol Bull 2005;131:260-300.
8. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52:89-99.
9. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003;54:283-94.
10. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-82.
11. Smith RS. The macrophage theory of depression. Med Hypotheses 1991;35:298-306.
12. Maier SF, Watkins LR. Cytokines for psychologists: implications for bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon I, Richard O, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SCJ, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease. Circulation 2003;107: 499-511.
14. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-92.
15. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:647-55.
16. Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 2005;105:409-16.
17. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-24.
18. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
19. Du Clos TW. Function of C-reactive protein. Ann Med 2000;32: 274-8.
20. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology. 5th ed. New York: WH Freeman; 2003.
21. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005;41:2502-12.
22. Nilsson MB, Langley RR, Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res 2005;23:10794-800.
23. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86.
24. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15:199-226.
25. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005;4:371-80.
26. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Mile JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-200.
27. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
28. Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav Immun 2002;16:569-74.
29. Szeleyni J, Selmmeczy Z. Immunomodulatory effects of antidepressants. Curr Opin Pharmacol 2002;4:428-32.
30. Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med 2005;15:202-6.
31. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-5.
32. Jilma B, Dirnberger E, Loscher I, Rumplmayr A, Hildebrandt J, Eichler HG, Kapiotis S, Wagner OF. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha 1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 1997;130:69-75.
33. Blazer DG. Depression in Late Life. 2nd ed. St. Louis: Mosby; 1993.
34. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997;52:M201-8.
35. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995;15:77-105.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV (DSM IV). Washington, DC: American Psychiatric Association; 1994.
37. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
38. Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, Matthews KA. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav Immun 2007;229-37.
39. Levine J, Barak Y, Chengappa KNR, Rapoport A, Rebey M, Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999;40:171-6.
40. Sjögren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun 2006;20:270-8.
41. Bower JE, Ganz PA, Aziz N, Olmstead R, Irwin MR, Cole SW. Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 2007;21:251-8.
42. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology. Hoboken, NJ: Wiley and Sons; 1989.
43. Davis MC, Zautra AJ, Younger J, Motivala SJ, Attrep J, Irwin MR. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav Immun 2008;22:24-32.
44. Frick RW. Accepting the null hypothesis. Mem Cognit 1995;23: 132-8.
45. Mervis CB, Robinson BF. Methodological issues in cross-group comparisons of language and/or cognitive development. In: Levy Y, Schaeffer J, editors. Language Competence Across Populations: Toward a Definition of Specific Language Impairment. Mahwah, NJ: Lawrence Erlbaum; 2003.
46. Bornstein M, Rothstein H. Comprehensive Meta-Analysis: A Computer Program for Research Synthesis. Englewood, NJ: Biostat; 1999.
47. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. New York: Academic Press; 1985.
48. Hedges LV, Vevea JL. Fixed- and random-effects models in metaanalysis. Psychol Methods 1998;3:486-504.
49. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315:1610-4.
50. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychol Bull 1979;86:638-41.
51. Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A. Acute phase proteins in major depression. J Psychosom Res 1997;43:529-34.
52. Vetta F, Ronzoni S, Lupattelli MR, Novi B, Fabbriconi P, Ficoneri C, Cicconetti P, Bruno A, Russo F, Bollea MR. Tumor necrosis factor-α and mood disorders in the elderly. Arch Gerontol Geriatr 2001;33(Suppl 1):435-42.
53. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
54. Spitzer RL, Kroenke K, Wiliiams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 1999;282:1737-44.
55. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993;41:176-81.
56. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301.
57. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE, Kern PA. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005;54:2305-13.
58. Guzik TJ, Mangalat D, Korbut R. Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 2006;57:505-28.
59. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83.
60. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-85.
61. Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997;41: 1140-2.
62. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379-88.
63. Ladwig KH, Mittag BM, Löwel H, Döring A, Wolfgang K. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003;17:268-75.
64. Danner M, Stanislav VK, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychcosom Med 2003;65:347-56.
65. Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 2005;19:555-63.
66. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P, for the PRIME study group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men. Circulation 2005;111: 2299-305.
67. Angstwurm MW, Gartner R, Ziegler-Heit-Brock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997;9:370-4.
68. Dreon DM, Slavin JL, Phinney SD. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 2003;73: 1245-52.
69. Salkeld BD, MacAulay JC, Ball RW, Cannon JG. Modulation of body temperature, interleukin-6, and leptin by oral contraceptive use. Neuroimmunomodulation 2001;9:319-25.
70. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP. Effect of postmenopausal hormones on inflammation-sensitive proteins: the postmenopausal estrogen/progestin interventions (PEPI) study. Circulation 1999;100:717-22.
71. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the depression-inflammation relationship: is depression a cause or a consequence? 66th Annual Scientific Meeting of the American Psychosomatic Society, 2008, Baltimore, MD.
72. Kop WJ, Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 2005;67:S37-41.
73. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
74. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res 1996;711:163-74.
75. Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 2001;15:7-24.
76. Meyers CA. Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol 1999;461:75-81.
77. Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Mitamura K. Depression from interferon therapy in patients with hepatitis C. Am J Psychiatry 1999;156:1120.
78. van den Biggelaar AHJ, Gussekloo J, de Craen AJM, Frölich M, Stek ML, van der Mast RC, Westendorp RGJ. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 2007;42:693-701.
79. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferruci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the health, aging, and body composition study. Biol Psychiatry 2003;54:566-72.
80. Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002;53: 873-6.
81. Capuron L, Ravaud A, Miller AH, Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 2004;18:205-13.
82. Matthews KA, Schott LL, Bromberger J, Cyranowski JM, Everson-Rose S, Sowers M. Is inflammation an antecedent or a consequence of depressive symptoms? Study of women's health across the nation. Paper presented at the 66th Annual Scientific Meeting of the American Psychosomatic Society, Baltimore, MD, 2008.
83. Hopkins SJ. The pathophysiological role of cytokines. Leg Med 2003;5:S45-57.
84. Miller AJ, Hopkins SJ, Luheshi GN. Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br J Pharmacol 1997;120:1274-9.
85. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8: 253-78.
86. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
87. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90:2522-30.
88. Ai AL, Kronfol Z, Seymour E, Bolling SF. Effects of mood state and psychosocial functioning on plasma interleukin-6 in adult patients before cardiac surgery. Int J Psychiatry Med 2005;35:363-76.
89. Allen-Mersh TGA, Glover C, Fordy C, Henderson DC, Davies M. Relation between depression and circulating immune products in patients with advanced colorectal cancer. J R Soc Med 1998;91:408-13.
90. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker, L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the health in men study (HIMS). Psychol Med 2007;37:1775-86.
91. Andrei AM, Fraguas R Jr, Telles RMS, Alves TCTF, Strunz CMC, Nussbacher A, Rays J, Iosifescu DV, Wajngarten M. Major depressive disorder and inflammatory markers in elderly patients with heart failure. Psychosomatics 2007;48:319-24.
92. Arai H, Takechi H, Wada T, Ishine M, Wakatsuki Y, Horiuchi H, Murayama T, Yokode M, Tanaka M, Kita T, Matsubayashi K, Kume N. Usefulness of measuring serum markers in addition to comprehensive geriatric assessment for cognitive impairment and depressed mood in the elderly. Geriatr Gerontol Int 2006;6:7-14.
93. Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, Göka E. IL-6 levels decrease with SSRI treatment in patients with major depression. Human Psychopharm 2005;20:473-6.
94. Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 1998;97:309-13.
95. Bremmer MA, Beekman ATF, Deeg DJH, Penninx BWJH, Dik MG, Hack CE, Hoogendijk WJG. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008;106:249-55.
96. Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 2005;104:305-13.
97. Dome P, Teleki Z, Rihmer Z, Peter L, Dobos J, Kenessey I, Tovari J, Timar J, Paku S, Kovacs G, Dome B. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry 2008 Jan 8 [Epub ahead of print] [doi:10.1038/sj.mp. 4002138].
98. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004;66:679-83.
99. Dressler WW, Balieiro MC, Ribeiro RP, Dos Santos JE. Depressive symptoms and C-reactive protein in a Brazilian urban community. Braz J Med Biol Res 2006;39:1013-9.
100. Elovainio M, Keltikangas-Järven L, Pulkki-Råback L, Kivimäki M, Puttonen S, Viikari L, Räsänen L, Mansikkaniemi K, Viikari J, Raitakari OT. Depressive symptoms and C-reactive protein: the cardiovascular risk in young Finns study. Psychol Med 2006;36:797-805.
101. Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg EM, Mistry S, Ronsaville D, Wesley R, Toomey C, Sebring NG, Reynolds JC, Blackman MR, Calis KA, Gold PW, Cizza G. Low bone mass in premenopausal women with depression. Arch Intern Med 2007;167: 2329-36.
102. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J 2005;150: 132-6.
103. Ferrucci L, Penninx BWJH, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried L, Guralnik JM. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;50:1947-54.
104. Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neuroscience 1997;247:228-33.
105. Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003;60:1009-14.
106. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999;33:407-18.
107. Häfner S, Baghai TC, Eser D, Schüle C, Rupprecht R, Bondy B. C-reactive protein is associated with polymorphisms of the angiotensin- converting enzyme in major depressed patients. J Psychiatr Res 2008;42:163-5.
108. Hekler EB, Rubenstein J, Coups EJ, Gilligan S, Kusnecov AW, Contrada RJ, Steiner MJ, Tannenbaum AK, Leventhal EA, Krause TJ. Inflammatory markers in acute myocardial infarction patients: preliminary evidence of a prospective association with depressive symptoms. J Appl Biobehav Res 2007;12:65-81.
109. Hemingway H, Shipley M, Mullen MJ, Kumari M, Brunner E, Taylor M, Donald AE, Deanfield JE, Marmot M. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol 2003;92:984-7.
110. Hornig M, Goodman DBP, Kamoun M, Amsterdam JD. Positive and negative acute phase proteins in affective subtypes. J Affective Disorders 1998;49:9-18.
111. Huang TL, Lee CT. T-helper1/T-helper 2 cytokine imbalance and clinical phentoypes of acute-phase major depression. Psychiatry Clin Neurosci 2007;61:415-20.
112. Huang TL, Lin FC. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuro-Psychopharmacol Biol Psychiatry 2007;31:370-2.
113. Hung YJ, Hsieh CH, Chen YJ, Pei D, Kuo SW, Sheu WHH, Chen YC. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol 2007;67:784-9.
114. Jacobson CM, Rosenfeld B, Pessin H, Breitbart W. Depression and IL-6 blood plasma concentrations in advanced cancer patients. Psychsomatics 2008;49:64-6.
115. Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 2005;19:555-63.
116. Jehn CF, Kuehnhardt D, Bartholomae A, Pfieffer S, Krebs M, Regierer AC, Schmid P, Possinger K, Flath BC. Biomarkers of depression in cancer patients. Cancer 2006;107:2723-9.
117. Joyce P, Hawkes C, Mulder R. Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 1992;32:1035-41.
118. Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S, Uchitomi Y. Plasma concentrations of interleukin-1β, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor-α of depressed patients in Japan. Neuropsychobiology 2001;43: 59-62.
119. Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, Gehl HB, Sipos V, Hohagen F, Schweiger U. Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 2005;67: 407-12.
120. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, omega-6: omega-3 fatty acids, and inflammation in older adults. Psychosom Med 2007;69:217-24.
121. Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry 2007;62:309-13.
122. Koenig HG, Cohen HJ, George LK, Hays JC, Larson DB, Blazer DG. Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults. Int J Psychiatry Med 1997;27:233-50.
123. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilä IM, Helkala EL, Gylling H, Nissinen A, Rauramaa R. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing 2007;36:443-8.
124. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89: 419-24.
125. Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Polish J Pharmacol 2000;52:237-41.
126. Kudoh A, Katagi H, Takazawa T. Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients. Cytokine 2001;13:104-8.
127. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:370-9.
128. Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, Cola C, Zanasi M, Troisi A, Siracusano A, Lauro R, Romeo F. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 2006;67:1760-6.
129. Lespérance F, Frasure-Smith N, Théroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004;161:271-7.
130. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen P, Leinonen M, Meyer-Rochow VB, Timonen M. The association between C-reactive protein levels and depression: results from the Northern Finland 1966 Birth Cohort Study. Biol Psychiatry 2006;60:825-30.
131. Loucks EB, Berkman LF, Gruenewald TL, Seeman TE. Relation of social integration to inflammatory marker concentrations in men and women 70 to 79 years. Am J Cardiol 2006;97:1010-6.
132. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol 1999;54A:M434-39.
133. Lutgendorf SK, Russell D, Ullrich P, Harris TB, Wallace R. Religious participation, interleukin-6, and mortality in older adults. Health Psychol 2004;23:465-75.
134. Lyness JM, Moynihan JA, Williford DJ, Cox C, Caine ED. Depression, medical illness, and interleukin-1β in older cardiac patients. Int J Psychiatry Med 2001;31:305-10.
135. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997;9: 853-8.
136. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferring receptor in major depression. J Affective Disorders 1995;34:301-9.
137. Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R. Increased serum interleukin-1 receptor-antagonist concentrations in major depression. J Affect Disord 1995;36:29-36.
138. McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med 2006;68:376-81.
139. Melamed S, Shirom A, Toker S, Berliner S, Shapira I. Association of fear and terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med 2004;66:484-91.
140. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001;11:203-8.
141. Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol 2005;95:317-21.
142. Miller GE, Rohdler N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med 2005;67:679-87.
143. Moorman AJ, Mozaffarian D, Wilkinson CW, Lawler RL, McDonald GB, Crane BA, Spertus JA, Russo JE, Stempien-Otero AS, Sullivan MD, Levy WC. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J Card Fail 2007;13:738-43.
144. Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005;67: 187-94.
145. Mussleman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158: 1252-57.
146. Owen BM, Eccleston D, Ferrier IN, Young AH. Raised levels of plasma interleukin-1β in major and postviral depression. Acta Psychiatr Scand 2001;103:226-8.
147. Pace TWW, Mietzko TC, Alagbe O, Musselman DL, Nemerhoff CB, Miller AH, Heim CM. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 2006;163:1630-33.
148. Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, Qi Q, Gu W, Pang X, Lui H, Lin X. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE 2008;3:e1392.
149. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004;25:492-9.
150. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, Kremastinos DT. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus with symptoms of depression. Am J Cardiol 2004;94:1326-8.
151. Pike JL, Irwin MR. Dissociation of inflammatory markers of natural killer cell activity in major depressive disorder. Brain Behav Immun 2006;20:169-74.
152. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med 2007;167:174-81.
153. Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res 2001;105:165-74.
154. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H. Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63:93-102.
155. Schins A, Tulner D, Lousberg R, Kenis G, Delanghe J, Crijns HJ, Grauls G, Stassen F, Maes M, Honig A. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatric Res 2005;39:137-44.
156. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 1995;41:534-8.
157. Shimbo D, Rieckmann N, Paulino R, Davidson KW. Relation between C-reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart 2006;92:1316-8.
158. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res 1996;64:161-7.
159. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 1995;762: 474-6.
160. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 1998;49:211-9.
161. Soygur H, Palaoglu O, Akarsu ES, Cankurtaran ES, Ozalp E, Turhan L, Ayhan IH. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2007;1242-7.
162. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003;33:667-74.
163. Suarez EC. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 2004;66:684-91.
164. Suarez EC. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 2003;65: 523-7.
165. Taylor SE, Lehman BJ, Kiefe CI, Seeman TE. Relationship of early life stress and psychological functioning to adult C-reactive protein in the Coronary Artery Risk Development in Young Adults Study. Biol Psychiatry 2006;60:819-24.
166. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1β in late-life depression. Am J Psychiatry 2005;162:175-7.
167. Tiemeier H, Hofman A, Ruud van Tuijl H, Kiliaan AJ, Meijer J, Breteler MMB. Inflammatory proteins and depression in the elderly. Epidemiology 2003;14:103-7.
168. Toker S, Shirom A, Shapira I, Berliner S, Melamed S. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol 2005;10:344-62.
169. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003;170:429-33.
170. Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, Bittner V, Rutledge T, Shaw LJ, Sopko G, Merz CNB. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia. J Am Coll Cardiol 2007;50:2044-50.
171. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the heart and soul study. Biol Psychiatry 2007;62: 314-20.
172. Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W, Tang Y. Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression. AustNZJ Psychiatry 2007;41:266-73.